OCTRI Biomedical Innovation Program, funding for drug discovery

The Oregon Clinical and Translational Research Institute (OCTRI) and the Office of Technology Transfer & Business Development (TTBD) are pleased to announce a funding opportunity to support drug discovery and therapeutic technology development efforts at OHSU.

The Biomedical Innovation Program (BIP) Drug Discovery/Therapeutic Track is a funding mechanism that aims to accelerate creative, trans-disciplinary drug discovery, and therapeutic development research. Examples of responsive projects may include (but are not limited to) research involving target validation, development of small molecules, antibodies, vaccines and biologics.

The current RFA can be found here.

Letters of intent are due on April 3, 2017.

Program highlights:

  • Up to $60,000 in funding
  • Project management and hands-on support from BIP staff
  • Access to project-specific mentors and experts

Questions? Please contact Jonathan Jubera at jubera@ohsu.edu, or visit the OCTRI Funding Opportunities page for more information.

Funding for this award is made possible by the OHSU Foundation via the University Venture Development Fund.

Bookmark and Share

Add Comment

About the Author

Julie Rogers is Research Development Associate in the Office of Research Funding & Development Services.

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives